chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I can't perform cna job today; Heart rate is extremely as if I been scared by something; Soar arm chills tiredness; Soar arm chills tiredness; Soar arm chills tiredness/My arm is sore; This spontaneous case was reported by a nurse and describes the occurrence of LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I can't perform cna job today), HEART RATE ABNORMAL (Heart rate is extremely as if I been scared by something), CHILLS (Soar arm chills tiredness), FATIGUE (Soar arm chills tiredness) and MYALGIA (Soar arm chills tiredness/My arm is sore) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form once. On 22-Jun-2021, the patient experienced CHILLS (Soar arm chills tiredness), FATIGUE (Soar arm chills tiredness) and MYALGIA (Soar arm chills tiredness/My arm is sore). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I can't perform cna job today) and HEART RATE ABNORMAL (Heart rate is extremely as if I been scared by something). At the time of the report, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I can't perform cna job today) and HEART RATE ABNORMAL (Heart rate is extremely as if I been scared by something) outcome was unknown and CHILLS (Soar arm chills tiredness), FATIGUE (Soar arm chills tiredness) and MYALGIA (Soar arm chills tiredness/My arm is sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up received on 23-Jun-2021 contained new events (loss of personal independence in daily activities, heart rate abnormal).
Information has been received from a consumer concerning her daughter, an 18 year old female, who on 01-APR-2007 was vaccinated with a dose, 0.5ml, of Gardasil. There was no concomitant medication. The consumer reported that on 01-APR-2007 after receiving the vaccination, her daughter "broke out in hives." At the time of this report, the consumer's daughter had not recovered from the hives. The patient sought unspecified medical attention. Additional information has been requested.
t102.8 @ ER 1850PM; TM, throat red, febrile sz;Motrin & ATB ordered; disch 20:25 condition improved
a few hours after my second shot i had a very dry mouth and a strange feeling in my tongue.  It lasted for about 3 or 4 hours.
Large circular, red ring, white inner circle, mark in middle, very itchy, new ones every day.  Located on torso, none on arms/legs/face
Within an hour of getting the booster starting I experienced aches and pain, running fever. I had fever since 12/08/2021 and around 12/09/2012 started vomiting and my temperature spiked up to 104.4. I called my doctor and was advised to go to the ER where they took my vitals, gave me saline, nausea medication and steroids.
9/27/21 PATIENT REPORTED GENERALIZED WEAKNESS, COUGH , CHEST CONGESTION, SOB AND CHEST PAIN. 9/29/21 SEEN IN THE ER AT TURKEY CREEK MEDICAL CENTER WITH COMPLAINTS OF SOB AND WEAKNESS.SpO2= 95 DX WITH COVID-19 BILAT PNEUMONIA , HYPOXIA ADMITTED TO INPATIENT HOSPITAL STATUS.  4 L OF OXYGEN. ALSO NOTED TO HAVE CHRONIC KIDNEY DISEAE WITH UNKNOWN STAGE.  dIED ON 10/4/21 WITH THE FOLLOWING DX: NSTEMI LIKLEY TYPE 1, ACUTE HYPOXIC RESP FAILURE, SEPSIS SECONDRAY TO COVID 19 PNEUMONIA AND POSSIBLE BACTERIAL PNEUMONIA, ACUTE CHF, ACUTE  RENAL FAILURE,. CAUSE OF DEATH: V.FIB DUE TO NSTEMI.
Initial misuse report received from a healthcare professional on 4 February 2014. A 7-year-old patient had received a dose of FLUZONE ID on unspecified date. It was an inappropriate age of vaccine administration. No adverse event was reported. List of documents held by sender: None.
Symptoms of event included: soreness in the area of injection, upset stomach, nausea, vomiting, diarrhea, elevated temperature (reported by recipient of vaccine as 99.9 degrees Fahrenheit). At the time of this report, recipient of vaccine has treated herself with rest and Pepto Bismol, which she states have alleviated a majority of her symptoms. Recipient of vaccine was referred to nursing hotline for additional treatment options and follow up care. Further result or outcome of adverse event is unknown at the time of this report.
Tinnitus in the ear on the same side as the shots. It has been confirmed a permanent tinnitus diagnosis now by audiologist. I do not listen to loud music or work in loud environments.
Extreme fatigue, aches all over began 6/2/16 eve and lasted several days. Took OTC meds and rested. She was ill for a week.
I experienced a miscarriage on February 27th, 2021.  I was approximately 10 weeks pregnant when I experienced the miscarriage. It was accompanied by severe pain/cramps in the abdomen and lower back.  Expected delivery would have been in September 2021.  This was my first pregnancy.
myalgia; lack of energy; feeling cold; tiredness; swollen; pain in arm; cold; shakiness; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), NASOPHARYNGITIS (cold), TREMOR (shakiness), ASTHENIA (lack of energy) and FEELING COLD (feeling cold) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MVI-ADULT and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), NASOPHARYNGITIS (cold) and TREMOR (shakiness). 12-May-2021, the patient experienced CHILLS (chills) and PYREXIA (fever). On 13-May-2021, the patient experienced LYMPHADENOPATHY (swollen). On 15-May-2021, the patient experienced ASTHENIA (lack of energy), FEELING COLD (feeling cold) and FATIGUE (tiredness). On an unknown date, the patient experienced MYALGIA (myalgia). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (pain in arm), NASOPHARYNGITIS (cold), TREMOR (shakiness), ASTHENIA (lack of energy), FEELING COLD (feeling cold), CHILLS (chills), PYREXIA (fever), FATIGUE (tiredness), LYMPHADENOPATHY (swollen) and MYALGIA (myalgia) outcome was unknown.
I received the shot around 1 PM and felt fine that night. Around 1 AM I woke up shivering and had a fever, terrible headache, and was very nauseous. That lasted until 1 am the next morning. I was sweating and dehydrated the next day. I had a lack of appetite the next week and nothing else happened until 05/01/2021 when the palm of my right hand was tingly. I did have the typical reaction after 2nd dose. I felt pretty ill afterwards and the 2nd day my armpit hurt and that lasted for 2-3 days. On the 3rd day I went and seen my Doctor and from my history I gave her she thought it was carpel tunnel so they treated it as that. I wore a brace for 2 weeks and had 24 hour NSAIDs for two days. I went in for my annual appointment and it hadn't changed at all so I am going to do a neurology study. I had tingling in my hand, forearm, and occasionally in my  neck and back. This is new and I have never had it before. This is we are all ongoing. Neurologist 07/24/2021.
Within a day or so (7April2021), the patient began to experience pretty severe headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Within a day or so (7April2021), the patient began to experience pretty severe headaches) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concurrent medical conditions included Renal disease.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Within a day or so (7April2021), the patient began to experience pretty severe headaches). At the time of the report, HEADACHE (Within a day or so (7April2021), the patient began to experience pretty severe headaches) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Within a day or so (7April2021), the patient began to experience pretty severe headaches which lasted several days before going away completely. The patient took Tylenol as treatment.  No concomitant medications were reported.
She has a localized reaction in her left arm that has lasted for 7 days. Including erythema, inflammation, and muscle tightness to the point of not being able to lift her arm over her shoulder.
This is a spontaneous report from a contactable physician. A 21-year-old female patient of an unspecified ethnicity received the first dosage of TRUMENBA, via an unspecified route of administration on an unspecified date to an unspecified date at single dose for immunisation. The medical history and concomitant medications were not reported. The patient experienced a very swollen arm after the first dose on an unspecified date with outcome of unknown.
This case was reported by a physician via sales rep and described the occurrence of rash in a adult female patient who received BEXSERO for prophylaxis. The patient's past medical history included eczema. On 26th June 2018, the patient received BEXSERO. On 28th June 2018, 2 days after receiving BEXSERO, the patient experienced rash and eye swelling. The patient was treated with ZYRTEC and BENADRYL. On an unknown date, the outcome of the rash and eye swelling were recovered/resolved. The reporter considered the rash and eye swelling to be related to BEXSERO. Additional details were provided as follows: The patient's initials and date of birth were unknown. The patient was 19 years old at the time of vaccination. The patient's mother reported rash, shoulder and arm, as well as one eye swelling 2 days after BEXSERO was administered in an unknown deltoid. The provider assumed it was related to the vaccine. The patient started on BENADRYL and ZYRTEC and symptoms mostly resolved within 4 days. The provider indicated patient's symptoms most likely had fully resolved by the time this event was reported to GlaxoSmithKline field medical and sales. All other information regarding vaccination details were unknown. The reporter agreed to follow up from GSK.
got second shot in left arm.  To this day in a lot of pain.  Cannot even lift half gallon of milk.
No adverse event; Bivalent dose administered after the BUD; Inappropriate age at vaccine administration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent dose administered after the BUD), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) and NO ADVERSE EVENT (No adverse event) in a 65-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 11-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent dose administered after the BUD) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent dose administered after the BUD), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent dose administered after the BUD) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration).    No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment information was not provided.
Day of first vaccine: Body aches, high fever, numbness, headaches, sleepiness, body pain, and sweating. Day of second vaccine: Body aches, high fever (from normal 95F to 104F), migraine headache, fatigue, sweating, body aches, and unable to move injected arm. Weeks after second vaccine: Daily headaches, fatigue, elevated heart rate, and irregular heart rate. Months after second vaccine: Weekly headaches, fatigue, elevated heart rate, chest pains, and fatigue. I am an athlete who can run for more than 12 hours straight. After this vaccine, it has taken months to feel even close to what I was before the vaccine. And, my headaches have not gone away. I was FORCED to take this vaccine, or I'd lose my employment.
Anaphylaxis, elevated heart rate, dizziness, throat tightness, nausea, abdominal pain
Information has been received from a physician concerning an "around 85 year old" male with an allergy to egg, who "recently" was vaccinated with "single dose vial" of Zostavax. Subsequently about a week later the patient developed an allergic dermatitis rash. The physician did not think that the rash was vaccine related. Medical attention was sought. Subsequently, the patient recovered from an allergic dermatitis rash. The product quality complaint was not involved. Additional information has been requested.
Within a few hours I experienced a hard squeeze inside around my heart. Not like an elephant on the chest, but from within.  My husband wanted to take me to the ER, but I opted to try and relax; take an aspirin and have him massage my back behind my heart. Within about 10 minutes it passed.  My arm was sore and achy the first night. The next morning about 10:00 am I began with chills, diarrhea, low grade fever, slight headache, body aches and fatigue. This lasted about 3 days. The child however lasted 3 more days. During this whole time I had difficulty with tightness in my chest that would not go away I also had edema in my ankles and feet that lingered all day. At night it would get better when I slept, but not go away. The pressure in my chest was not going  away, so I went to my primary care doctor. We went over my medications, none of which are new to me and the only thing he could conclude was the vaccine reaction, so he did lab work. I am still waiting on the Cardiac enzymes and D-dimer for blood clots, but the C-reactive protein was very high. He gave me an injection of steroid mixed with an anti inflammatory medication and toroidal. It took about 6 hours but the pain my chest went away and today I am feeling better. He diagnosed me with myocarditis and has since added a short term dose of meloxicam, lasix and potassium to help get the excess fluid off.
Patient (me) had been hiking for first time in many months.  Arrived for vaccine with very sore, tired leg muscles.   Four hour after injection, patient exhibited extreme bilateral pain in muscles in the thigh. I would rate the pain as 9/10.  Pain lasted 5 minutes and resolved.  An hour later the pain returned this time for more than 20 minutes.  Twenty-four hours later, same muscles are exhibiting a strong burning sensation. Patient was also somewhat dehydrated at the time.
Breakthrough case admission after 3 vaccines Pfizer 4/14/21 Lot# Ew0169;  Pfizer 5/5/21 Lot# Ew0179;  Pfizer 1/10/22 Lot# FF259
Patient experienced cramping immediately after administration and then "tingly throat" approximately 10 minutes after administration. I administered 50 mg diphenhydramine and continued to observe patient. Patient reported that tingling had stopped and she was feeling better prior to departure from observation area at 7:49 am. Counseled patient on potential for allergic reaction days to weeks after administration.
4/7/2021: Red arm started at site with ecchymosis, redness extended down the arm.  4/9/2021: Rash with pustules, leak clear fluid, pruritis 4/12/2021: Eye swelling, red arm and rash subsided.
Information has been received from a consumer's wife concerning his husband, a 77 year old male patient with cancer and chemotherapy since 01-APR-2009 who on 12-MAY-2008 was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot number not reported). Concomitant therapy included doxorubicin and cyclophosphamide. The caller stated that on 25-JAN-2010 her husband developed shingles; she believed it was less effective because of the chemo. The patient sought for unspecified medical attention. Follow up information has been received which indicated that the patient received immunization at his county's Health Department and there was no doctor involved. In March 2009 the patient was diagnosed with Non-Hodgkin's Lymphoma. On 01-APR-2009 he began chemotherapy. The patient's last chemotherapy was on 22-JUL-2009. It was reported that recovery was going well. In January 2010 the patient came down with shingles. They had been told that chemotherapy, at times, could take immunity away. Upon internal review, "diagnosed with Non-Hodgkin's Lymphoma" was considered to be an other important medical event. Additional information has been requested.
Pt. noticed burning when vaccine was injected. There was a lump at injection site. Site became red and swollen and warm to the touch.
SOB and chest tightness after vaccine.  Pulse and RR within normal limits.  Gave albuterol - examined by physician in office.  Felt to be of anxiety or panic attach related and the albuterol was maybe more of a placebo effect.
chills and shivering; trembling; feeling very cold; nausea; headache; confusion; feeling down; Feeling weird; was in bed the next day all day long; pain on injection site; redness on injection site; swelling on injection site; hot on injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (1st dose received on unknown date for further tolerence refer case US2020211104).   On 20th October 2020, the patient received the 2nd dose of Shingrix and Influenza vaccine Quadrivalent unspecified season. In October 2020, less than a week after receiving Shingrix and Influenza vaccine Quadrivalent unspecified season, the patient experienced injection site pain, injection site erythema, injection site swelling, injection site warmth, nausea, headache, confusion, feeling down, weird feeling and somnolence. On 21st October 2020, the patient experienced chills, tremor and feeling cold. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling, injection site warmth, chills, tremor, feeling cold, nausea, headache, confusion, feeling down, weird feeling and somnolence were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, injection site warmth, chills, tremor, feeling cold, nausea, headache, confusion, feeling down, weird feeling and somnolence to be related to Shingrix and Influenza vaccine Quadrivalent unspecified season.  Additional details were as follows: The age at vaccination was not reported. 3 months ago patient had her shingrix and pneumonia vaccine and had events like body ache and arm pain. Patient reported that she received the 2nd dose of Shingrix on 20th October,2020 on right arm and same day she also had Flu vaccine. It was reported that patient experienced pain, redness, and swelling and hot on injection site also on Wednesday October 21st, 2020 in the early morning she had chills and shivering, trembling, and feeling very cold and nausea, headache and confusion. Patient described it as "feeling down and weird" and also she was in bed the next day all day long. It was reported that her symptoms have not resolved. The reporter consented to follow up. This case has been linked with US2020211104 case reported by the same reporter.
AFTER RECIEVING THE COVID 19 PFIZER VACCINE PATIENT WAITED THE REQUIRED TIME OF 15 MINUTES AND LEFT. ABOUT 30 MINS LATER PATIENT COMES BACK COMPLAINING OF TINGING AND ITCHING OF THROUT AND BODY. PATIENT HAS NO BREATHING ISSUES. I CHECKED HER BP AND PULSE BOTH WITHIN NORMAL RANGE. SHE SAT FOR A FEW MINUTES AND STILL HAD THE TINGING AND ITCHING SO I THEN GAVE HER AN INJECTION OF DIPHENHYDRAMINE AND OBSERVED HER FOR 30 MINS. ALL SYMPTOMS SUBSIDED AND PATIENT FELT BETTER. I ADVISED HER TO NOT DRIVE SHE CALLED HER MOTHER TO PICK HER UP. PATIENT REFUSED TO GET CHECKED BY EMS.
Had dull ache and knot in arm since getting vaccine.  On day 8 he developed chills, body aches, hot and swollen arm, itchy, as well as fatigue, weakness, sneezing, coughing, congestion.
Scratchy throat, cough within 10 minutes of vaccine administration; some nausea, abdominal cramps and headache.  Also felt burning during vaccine administration. Given oral benadryl with improvement.  Observed one hour total after vaccine.  Called 2 hours post vaccine with almost complete resolution of all symptoms.  instructed to not get second dose and follow up with PCP/allergist.
Information was received from a lawyer regarding a case in litigation. It is alleged in litigation that a male patient, on or about 01SEP2010 was vaccinated with a dose of ZOSTAVAX (Merck) for its intended purpose. On or about 07SEP2010, he began to experience various neurological symptoms. As a direct and proximate result of ZOSTAVAX (Merck), the patient was diagnosed with acute disseminating encephalomyelitis (ADEM) on or about 28SEP2010. The patient continues to experience ongoing neurological symptoms, such as numbness and paralysis. His neurological symptoms have resulted in physical limitations not present prior to the vaccine. Patient experiences mental and emotional distress due to physical limitations and seriousness of his condition. Upon internal review, acute disseminating encephalomyelitis was determined to be a significant medical event. Additional information has been requested.
patient describes worsening of her chronic low level tinnitus immediately after receiving Pfizer Covid19 2nd dose.
Symptoms: itching, pain, red rash, fluid-filled blisters, fatigue, and orofacial pain. Treatment: Valacyclovir HCL 1G tablet three times a day/7 days and gabapentin 100MG capsule 2 times a day and then 3 times at night Course: symptoms began on April 18, diagnosis received April 22 Outcome: still pending treatment
muscle ache/pain from hips up.  Fingers really ached and could hardly bend. seems to be getting better